In his latest article, Tyler Freier breaks down how the rise of GLP-1 weight-loss drugs is reshaping consumer habits, and entire industries. As people eat out less and shift toward healthier choices, brands that adapt through innovation and strategic pivots are best positioned to win in 2025.
Click here to read the article.
Contact Us